The Effect of LMWH on ICSI in Patients With Unexplained Infertility and Negative Immunological Markers

• Status: Completed
• Trial end date: 2016-03-01
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to assess the efficacy of LMWH treatment in women with unexplained infertility and negative immunological markers undergoing ICSI.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Ain Shams University
• Treatments: Enoxaparin; Heparin, Low-Molecular-Weight; Pharmaceutical Solutions

Criteria

Inclusion Criteria:

• age less than 38 years

• at least 12 months of infertility

• women with unexplained infertility

Exclusion Criteria:

• age more than or equals 38 years

• serum AMH level less than or equals 1 ng/ml

• patients of anticoagulant therapy

• immune-compromised patients

• patients with contraindications to low molecular weight heparin

• positive immunological markers

• patients with other than unexplained infertility

• male factor infertility

• refusal of participation

• patients with unexpected poor or over response during induction of ovulation